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Case Report
Perioperative Anaesthetic Management of a Patient with relapsed Aplastic
Anaemia
Aliya Ahmed, Abdul Monem
Department of Anaesthesia, Aga Khan University Hospital, Karachi.

Abstract
Aplastic anaemia occurs due to failure of blood cell
production by bone marrow. All blood cell counts are low.
Untreated patients may die within one year mainly due to
uncontrolled infection due to neutropenia. Anaemia and
thrombocytopenia cause troublesome symptoms and necessitate frequent red cell and platelets transfusions. Surgery
poses a very high risk for these patients because of the several complications that can occur in the perioperative period. In this paper we report on a patient with relapsed aplastic anaemia who was optimized preoperatively and underwent a total abdominal hysterectomy under general anaesthesia.

Introduction
Aplastic anaemia is defined as the presence of pancytopenia in the peripheral blood and a hypocellular marrow in which normal haemopoietic marrow is replaced by
fat cells.1 It occurs due to failure of blood cell production by
the bone marrow.2 Typically all blood cell counts are low.
Because of the deficiency of haemopoietic cells, the patient
is at a risk of several complications. Neutropenia leads to a
high risk of infection. Thrombocytopenia causes bruising
and spontaneous bleeding and moderate to severe anaemia
is usual due to the decreased number of circulating red
cells.1-3 These risks are increased several fold in the perioperative period and any surgical intervention in these patients
should be undertaken only after careful contemplation and

weighing the balance between risks and benefits of the surgery.
We report on a patient with relapsed aplastic
anaemia who presented with menorrhagia, failed to respond
to conservative management and underwent total abdominal
hysterectomy under general anaesthesia.

Case Report
A 35 year old woman, known case of idiopathic
aplastic anaemia since 2000, presented with a history of
menorrhagia for several months. The patient had received
Antilymphocyte Globulin and remained in remission until
September 2001, but then relapsed. Since then she had been
receiving packed red cells and platelet transfusions every 710 days. She was also receiving cyclosporine. Because of
the high risk of surgery she was put on conservative management for her menorrhagia. The haematologist's advice
was to perform surgery only as the last resort. Her menorrhagia did not respond to conservative management and a
total abdominal hysterectomy was planned.The patient was
very emotionally disturbed by her symptoms and wanted a
surgical intervention. The increased risks of surgery, due to
the aplastic anaemia, were explained to her and she was prepared to take the risk.
Her haemoglobin was 6.8g/dl, platelet count was
13x109/l and white cell count was 2.8x109/l. Her preoperative optimization was done in collaboration with the haematology department and the blood bank. She was transfused

Table. Peri-operative laboratory results of the patient with alplastic anaemia.

Laboratory variables

On admission

Pre-operative

1st Postoperative

Normal range

day
Haemoglobin (gm/dl)

6.8

9.5

11.5

13.7 - 16.3

18.8

28.6

32.4

41.9 - 48.7

Leukocytes(x109/L)

2.8

3.2

2.7

4.0 - 10.0

Platelets(x109/L)

13
13

82

150 - 400

Haematocrit (%)

13

(brefore transfusing
platelets)

transfused packed red cells and her haemoglobin
was raised to 9.5g/dl and white cell count to 3.2x109/l. On
account of the short half life of platelets, 10 units of
platelets were transfused immediately preoperatively. The
aim was to keep the platelet count above 50x109/l intraoperatively (Table).
General Anaesthesia was induced with intravenous
pethidine, thiopentone and atracurium after careful preoxygenation. Aseptic precautions were taken for intravenous
access and endotracheal intubation and prophylactic antibiotics were administered. The monitoring included a continuous electrocardiogram, non-invasive blood pressure, oxygen saturation, end-tidal carbondioxide temperature and
urine output. The surgery was uneventful and lasted about
ninety minutes. Surgical blood loss was approximately
500ml, which was replaced with packed red cells. Six units
of platelets were transfused intraoperatively. The patient
remained stable throughout the procedure with adequate
urine output. Extubation was atraumatic and the patient
made a good recovery. Postoperative pain relief was provided with pethidine using patient controlled intravenous analgesia. Regular blood counts were performed perioperatively (Table). Postoperative course was uneventful and the
patient was discharged home on the fifth postoperative day.

Discussion
Aplastic Anaemia is characterized by pancytopenia
with depletion of all types of blood cells.1-3 The problems
associated with aplastic anaemia, that is, anaemia, thrombocytopenia and neutropenia, all pose a major threat to any
patient requiring surgical intervention. The risks and benefits of surgery must be weighed carefully prior to making
the decision to perform a surgical procedure on these
patients. In order to avoid serious complications, adequate
optimization is essential before proceeding with any elective surgery.4 The advice of an experienced haematologist
must be sought early and the support of a well equipped
blood bank is essential to ensure a positive outcome.4,5
Anaemia should be corrected with packed red cell
transfusion to a level of at least 8gram/dl in the absence of
cardiac problems, while 10gm/dl is still taken as the minimum safe level by most anaesthesiologists for patients with
ischaemic heart disease.6 Thrombocytopenia, if not corrected preoperatively, can lead to serious intra and postoperative haemorrhage. Platelets have a very short half life and
therefore, in order to achieve maximum benefit, it is important to carefully time the platelet transfusion.7 These
patients are receiving regular transfusions of both red cells
and platelets, but their counts fall rapidly and adequate
amount of blood and blood products must be available for
the immediate perioperative period. Presence of neutropaenia makes the patient prone to infection, therefore, it is
mandatory to take aseptic precautions for all anaesthetic
maneuvers including intravenous cannulation, endotracheal

intubation etc. For the same reason perioperative antibiotic
cover is essential.4,5,8 Regional anaesthesia (spinal/epidural)
is absolutely contraindicated in the presence of thrombocytopaenia4,8,9, therefore general anaesthesia is the only technique available for these patients.
When our patient first presented with menorrhagia, it
was decided to put her on conservative management and to
perform surgery only if all other measures failed. A close
collaboration was maintained between the gynaecologist
and the haematologist. The patient did not respond to conservative management, therefore a total abdominal hysterectomy was planned. The anaesthesiology team performed a thorough preoperative assessment and both the
anaesthesiology and the haematology teams worked to
acquire preoperative optimization.
Good postoperative pain relief was essential to allow
deep breathing and adequate coughing so that secretions
would not retain in the lungs, to prevent pulmonary infection. Low platelet counts rendered regional analgesia
absolutely contraindicated in this patient, therefore, after
preoperative counseling, patient controlled intravenous
analgesia with pethidine was employed. This proved to be
satisfactory. She required red cell and platelet transfusions
on the 2nd and 4th postoperative day, with an uneventful and
smooth recovery. She was discharged on the 5th postoperative
day. Although the patient still requires platelet and red cell transfusions every 7-10 days, she is pleased that her troublesome
symptom of menorrhagia has now been relieved.
The incidence of aplastic anaemia is 5-10 fold higher in the Oriental countries like Japan and Thailand compared to the Western world.1,2 The authors have strived to
retrieve literature about the perioperative anaesthetic management and problems associated with aplastic anaemia.
Most of the literature that could be retrieved from web
search originated from either Japan or Russia.4,5,8,9 These
articles have highlighted the problems associated with surgery and anaesthesia in these patients, which are similar to
those that we faced with our patient. They have described
their anaesthetic management and have stressed upon adequate replacement of blood components for a successful
outcome.

Conclusion
The anaemia, thrombocytopenia and neutropenia associated with aplastic anaemia pose a major threat to the patient
in the perioperative period. The decision for surgery should be
made carefully and surgery undertaken only if a patient has a
life threatening or debilitating condition requiring surgical
intervention. A thorough preoperative assessment and intensive preparation of the patient is mandatory before taking him
or her to the operation theatre. Efficient blood bank services
and good communication, cooperation and coordination
between the surgeon, haematologist and anaesthesiologist are essential for a successful outcome of any surgical intervention in these patients.
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